Homeopathic Drugmaker Puts Up $1M To End False Ad Claims

Law360, New York (August 15, 2013, 3:54 PM EDT) -- Homeopathic treatment manufacturer Heel Inc. agreed Wednesday to dial down its health claims tied to its over-the-counter remedies and pay a $1 million class settlement to resolve accusations that it exaggerated the products’ effectiveness to consumers.

Albuquerque-based Heel will compensate consumers seeking refunds for purchases of any of its products labeled as homeopathic, up to a limit of $150 per buyer, according to settlement documents filed in California federal court. The company also agreed to add disclaimers clarifying the scientific underpinnings of its marketing of drugs...
To view the full article, register now.




Case Information

Case Title

Mason v. Heel, Inc.

Case Number



California Southern

Nature of Suit

Fraud or Truth-In-Lending


Gonzalo P. Curiel

Date Filed

December 21, 2012

Law Firms

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.